Arineta Releases SpotLight Duo

Arineta Cardiac Imaging has received U.S. Food and Drug Administration 510(k) clearance for its SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners. The two products are touted by the company as the only dedicated cardiovascular CT system, and the Duo system adds high resolution thoracic clinical capability, including for lung cancer, COVID 19, and other pulmonary diseases. Additionally, both the SpotLight and SpotLight Duo systems add extended coverage for peripheral vascular and runoff studies, a rapidly growing procedure for vascular therapies.
 
 “The new SpotLight systems continue Arineta’s history of clinical innovation,” Arineta CEO Scott Schubert said. “Our vision is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease—the number one cause of death and costs for healthcare worldwide.”
 
The SpotLight system is a 25cm Field of View (FOV) dedicated CCT system, enabled by Arineta’s proprietary Stereo CT technology. SpotLight has best-in-class specifications for temporal resolution (120 msec), one beat whole-heart coverage (14cm), spatial resolution (0.5mm detector), and X-ray tube power for superior image quality (139kW effective), according to the company. SpotLight Duo is the second generation of Arineta CT technology, with 45cm high resolution scanning for full cardiothoracic clinical applications. Both systems include workflow advances for higher patient throughput.
 
“The recent change in guidelines from the ACC and AHA are now clear that cardiac CT is the Level 1A evidence recommended test for diagnosis of stable and acute chest pain,” said Chaim Lotan, M.D., professor at Hadassah-Hebrew University. “According to the World Health Organization, four of the top six causes of death are cardiovascular and thoracic diseases.”
 
ArinetaSpotLight and SpotLight Duo systems are being sold and serviced directly by Arineta.
 
Arineta is an Israeli company that develops and produces cardiovascular imaging solutions. Arineta’s flagship product is SpotLight Duo, the world’s first dedicated single-heartbeat, whole heart Cardiovascular and Thoracic CT, based on the company’s proprietary Stereo CT technology.  Among Arineta’s scientists are the inventors of the multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies.